Filing Details
Krystal Biotech, Inc. (NASDAQ:KRYS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 03, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:KRYS
Krystal Biotech, Inc. (KRYS) Files Quarterly Report for Q0
Filing Details Krystal Biotech, Inc. (NASDAQ:KRYS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 03, 2026. The Healthcare company…
Market Context
Krystal Biotech, Inc.'s stock currently trades at $312.57 with a market capitalization of $7.2B.
The 10-Q provides Krystal Biotech, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Krystal Biotech, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View KRYS Stock Page
Frequently Asked Questions
Where can I read KRYS's SEC filings?
Browse all filings on our KRYS SEC filings page.
What types of SEC filings does Krystal Biotech, Inc. file?
Public companies like Krystal Biotech, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.